期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

缺血性心力衰竭血运重建策略 被引量：3

Revascularization strategies for ischemic heart failure
原文传递
导出
摘要 缺血性心脏病是心血管系统常见疾病,随着时间推移可进展为缺血性心力衰竭(IHF),发生心肌缺血及心律失常事件的风险明显增加,患者预后较差。血运重建治疗可挽救慢性缺血导致的顿抑心肌和冬眠心肌,提高左心室射血分数,是IHF患者的重要治疗手段。文章重点介绍IHF血运重建策略方面的最新进展。 Ischemic heart disease is one of the most common cardiovascular diseases and may eventually progress to ische mic heart failure（IHF）,giving rise to elevated rates of ischemic events,arrhythmic events,and poor prognosis. Revascular ization has been proven to recruit hibernating or stunned myocardium to improve overall myocardial contractility and it plays a crucial role in the treatment of IHF. This article reviews recent advances in the revascularization strategies for ischemic heart failure.
作者 李为民 李俭强
机构地区 哈尔滨医科大学附属第一医院心内科
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第7期652-654,共3页 Chinese Journal of Practical Internal Medicine
基金 哈尔滨市科技攻关计划项目(2007AA3CS082)
关键词 缺血性心力衰竭 血运重建 经皮冠状动脉介入治疗 冠状动脉旁路搭桥手术 ischemic heart failure revascularization percutaneous coronary intervention coronary artery bypass grafting
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1Buszman P,Szkróbka I,Gruszka A,et al.Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy[J].Am J Cardiol,2007,99:36-41.
  • 2Yang JH,Choi SH,Song YB,et al.Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction[J].Am J Cardiol,2013,112:623-629.
  • 3Kunadian V,Pugh A,Zaman AG,et al.Percutaneous coronary intervention among patients with left ventricular systolic dysfunction:a review and meta-analysis of 19 clinical studies[J].Coron Artery Dis,2012,23:469-479.
  • 4Wijns W,Kolh P,Danchin N,et al.Guidelines on myocardial revascularization Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);European Association for Percutaneous Cardiovascular Interventions (EAPCI)[J].Eur Heart J,2010,31:2501-2555.
  • 5Garcia S,Sandoval Y,Roukoz H,et al.Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease:a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies[J].J Am Coll Cardiol,2013,62:1421-1431.
  • 6Pijls NH,Fearon WF,Tonino PA,et al.Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease:2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study[J].J Am Coll Cardiol,2010,56:177-184.
  • 7Dangas GD,George JC,Weintraub W,et al.Timing of staged percutaneous coronary intervention in multivessel coronary artery disease[J].JACC Cardiovasc Interv,2010,3:1096-1099.
  • 8Kapur NK,Jumean MF.Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure[J].Curr Heart Fail Rep,2013,10:177-184.
  • 9沈敏,刘兵,王海昌,郭文怡,李伟杰,刘丽文,张军.心脏再同步化治疗慢性心衰的短期疗效观察[J].解放军医学杂志,2008,33(8):1016-1018. 被引量：10
  • 10Heldman AW,DiFede DL,Fishman JE,et al.Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy:the TAC-HFT randomized trial[J].JAMA,2014,311:62-73.

二级参考文献16

  • 1郭继鸿.深入认识心脏再同步化治疗心力衰竭的机制[J].中国心脏起搏与心电生理杂志,2006,20(4):283-284. 被引量：62
  • 2蔡彬妮,黄卫斌.优化心脏再同步化治疗顽固性心力衰竭的策略[J].中国心脏起搏与心电生理杂志,2007,21(1):67-69. 被引量：12
  • 3Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin[J].J Neurochem, 2003, 84(5): 1162 -1172.
  • 4Chong KS, Gardner RS, Morton JJ, et al. Plasma concentrations of the novel peptide apelin are decreased in patients with choronic heart failure[J]. Eur J Heart Fail, 2006, 8(4): 355-360.
  • 5Tatemoto K, Hosoya M, Habata Y, et al. Isolation and character- ization of a novel endogenous peptide ligand for the human APJ recep- tor[J]. Biochem Biophy Res Commun, 1998, 251(2): 471-476.
  • 6Assmus B, Honold J, Schachinger V, et al. Transcoronary trans- plantation of progenitor cells after myocardial infarction[J]. N Engl J Med, 2006, 355(12): 1222-1232.
  • 7Kocher AA, Schuster MD, Szabolcs MJ, etal. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function[J].. Nat Med, 2001, 7(4): 430-436.
  • 8Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months" follow-up data from the randomized, controlled BOOST (BOne marrow trans [er to enhance ST-elevation infarct regeneration) trial[J]. Circula- tion, 2006, 113(10): 1287-1294.
  • 9Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators[J]. Cell Biochem, 2006, 98(5): 1076 -1084.
  • 10Xu M, Uemura R, Dai Y, etal. Invitro and in vivo effects of bone marrow stem cells on cardiac structure and function[J]. J Mol Cell Cardiol, 2007, 42(2): 441- 448.

共引文献15

同被引文献27

引证文献3

二级引证文献15

中国实用内科杂志
2014年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部